Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

80
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
80
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

27
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Developing a Patient Reported Outcomes Measure for Children with Heart Failure: A Qualitative Study Design.

American heart journal·2026
Same author

Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39).

JCO oncology practice·2026
Same author

What patients would have liked to have known in advance about physical function due to cancer treatment.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Evaluating different scoring algorithms to assess communication ability for individuals living with Angelman syndrome: the Observer-Reported Communication Ability (ORCA) measure.

Journal of patient-reported outcomes·2026
Same author

Correction: Identifying High-Priority Ecological-Level Indicators of Structural Racism in Black and Hispanic/Latino Communities.

Journal of racial and ethnic health disparities·2026
Same author

Frailty phenotype in adults with sickle cell disease.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same journal

Guideline-Directed Medical Therapy Use and Dose Optimization after TAVR in Patients with Persistent HFrEF.

Journal of cardiac failure·2026
Same journal

Heart Failure Pharmacotherapy Across the TAVR Continuum.

Journal of cardiac failure·2026
Same journal

Time to benefit of incretin-based therapies in adiposity-related heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis.

Journal of cardiac failure·2026
Same journal

Predictors and Outcomes of Heart Failure Diagnosis in the Community When Compared to Acute Care Settings: Insights from Linked Administrative Health Databases.

Journal of cardiac failure·2026
Same journal

Digitalis Today: From Doctrine to Disrepute to Disciplined Reconsideration.

Journal of cardiac failure·2026
Same journal

What Are HFpEF Mimics and What Are They Mimicking? Insights Into Our Conceptualization of Heart Failure With Preserved Ejection Fraction as a Disease.

Journal of cardiac failure·2026
See all related articles

Related Experiment Video

Updated: Sep 8, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.5K

Do PRO Measures Function the Same Way for all Individuals With Heart Failure?

Theresa M Coles1, Li Lin1, Kevin Weinfurt1

  • 1Center for Health Measurement, Department of Population Health Sciences, Duke University, Durham, North Carolina.

Journal of Cardiac Failure
|June 12, 2022
PubMed
Summary
This summary is machine-generated.

Patient-reported outcome (PRO) measures may inaccurately reflect women's quality of life in heart failure. Differences in question interpretation, known as differential item functioning, threaten valid comparisons between men and women.

Keywords:
Heart failuredifferential item functioningpatient-reported outcomespsychometricwomen

More Related Videos

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

8.2K
Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism
09:10

Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism

Published on: January 12, 2019

13.3K

Related Experiment Videos

Last Updated: Sep 8, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.5K
Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

8.2K
Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism
09:10

Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism

Published on: January 12, 2019

13.3K

Area of Science:

  • Cardiology
  • Psychometrics
  • Health Equity Research

Background:

  • Patient-reported outcome (PRO) measures are crucial for assessing quality of life in heart failure.
  • Women with heart failure report poorer quality of life than men on current PRO measures.
  • A key assumption is that men and women interpret PRO questions identically.

Purpose of the Study:

  • To examine the potential for differential item functioning (DIF) in heart failure PRO measures.
  • To highlight the implications of DIF for comparing outcomes between sexes and across clinical trials.
  • To address the impact of DIF on identifying and rectifying health inequities in heart failure care.

Main Methods:

  • This study reviews existing research on DIF in heart failure PROs.
  • It outlines the psychometric concept of DIF and its relevance to clinical outcomes.
  • The authors discuss current research gaps and propose strategies to mitigate DIF.

Main Results:

  • Differential item functioning (DIF) poses a significant threat to the validity of PRO data in heart failure.
  • If not addressed, DIF can lead to inaccurate comparisons of quality of life between men and women.
  • This invalidity has critical implications for clinical trial interpretation and health equity.

Conclusions:

  • Ensuring the validity of PRO measures is paramount for accurate interpretation of heart failure outcomes.
  • Addressing DIF is essential for valid subgroup comparisons and for advancing health equity.
  • Future research should focus on methods to detect and correct DIF in heart failure PROs.